| 3KRR: reference: Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805., Baffert F, Regnier CH, De Pover A, Pissot-Soldermann C, Tavares GA, Blasco F, Brueggen J, Chene P, Drueckes P, Erdmann D, Furet P, Gerspacher M, Lang M, Ledieu D, Nolan L, Ruetz S, Trappe J, Vangrevelinghe E, Wartmann M, Wyder L, Hofmann F, Radimerski T, Mol Cancer Ther. 2010 Jul;9(7):1945-55. Epub 2010 Jun 29. PMID: 20587663 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).